CME Group say-on-pay fails; all equity directors re-elected at 2022 annual meeting

CME GROUP INC.

Shareholders rejected advisory vote on executive compensation: 211M against vs 64M for (76.7% against).
All 17 Equity Directors re-elected to 2023; Terrence Duffy received 89% of votes cast.
Ratification of Ernst & Young as auditor passed with 288M votes for, 9.6M against.
Omnibus Stock Plan, Director Stock Plan, and Employee Stock Purchase Plan all approved.
Class B-1 and B-3 director elections lacked quorum; incumbents continue as holdovers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.